Diabetes and COVID-19: A Review

Area of Science:

• Endocrinology
• Infectious Diseases
• Public Health

Background:

• Coronavirus Disease 2019 (COVID-19) emerged in late 2019, rapidly causing a global pandemic.
• COVID-19 disproportionately affects individuals with diabetes, leading to poorer health outcomes.
• Pre-existing conditions like cardiovascular disease (CVD) and chronic kidney disease (CKD) exacerbate COVID-19's impact on diabetic patients.

Purpose of the Study:

• To review the current understanding of COVID-19's impact on diabetes.
• To explore the pathophysiological mechanisms linking COVID-19 and diabetes complications.
• To discuss the management strategies for diabetes in the context of COVID-19.

Main Methods:

• Literature review of existing studies on COVID-19 and diabetes.
• Analysis of pathophysiological pathways involved.
• Synthesis of current clinical management guidelines.

Main Results:

• COVID-19 infection is associated with increased morbidity and mortality in diabetic individuals.
• Factors such as age, smoking, obesity, CVD, CKD, poor glycemic control, and diabetes duration worsen outcomes.
• Specific pathophysiological mechanisms include viral interaction with the ACE2 receptor and inflammatory responses.

Conclusions:

• COVID-19 presents a significant threat to the diabetic population, necessitating tailored management approaches.
• Understanding the interplay between COVID-19 and diabetes is crucial for mitigating adverse effects.
• Further research is needed to optimize treatment strategies for diabetic patients during the pandemic.